Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

News You Need to Know Today
News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk
Tuesday, April 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI-enabled HF implant impresses | Cardiologist lied about penile cancer | How to talk about GLP-1 drugs | Risks after T-TEER
SAVR linked to ‘excellent’ long-term survival | A new cardiac care certification | AI for congenital heart disease
CMS targets cardiologists for payment model | The first TAVR of its kind | AI has a long way to go | PFA tech gains new approval
February's Top Stories: Multiple recalls | Statin labeling needs to be revised | A new device for AFib patients | TAVR vs. SAVR
FDA confirms heart pump recalls | Federal funding for PAD | Recreational Adderall | New stroke devices | Ultrasound RDN in Japan
News Alert: FDA confirms more recalls for Johnson & Johnson heart pumps
FDA approves next-gen HF device | Inconsistent radiation doses | Treating ‘no-option’ patients | New GLP-1 data | CHD risks

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …19
    • Page 20
    • Page 21
    • Page 22
    • Current page 23
    • Page 24
    • Page 25
    • Page 26
    • Page 27 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme